Psyence Biomedical Ltd (PBM)

Dec 12, 2025

Psyence Biomedical Ltd. (PBM) -5.7% in After-hours: Despite No Clear Catalyst - Stocks Telegraph

Dec 12, 2025

Dec 12, 2025

Psyence BioMed Advances Phase IIb Clinical Trial and Expands Board - MSN

Dec 12, 2025

Dec 10, 2025

Check out these key findings about Psyence Biomedical Ltd (PBM) - setenews.com

Dec 10, 2025

Dec 09, 2025

Rapid Surge: Psyence Biomedical’s Unexpected Stock Movement - StocksToTrade

Dec 09, 2025

Dec 09, 2025

Psyence BioMed (PBM) Stock: Drives Forward with Phase IIb Trial and Unique Longevity Science Position - parameter.io

Dec 09, 2025

Dec 09, 2025

Psyence Biomedical Ltd. (PBM) Stock: Drops, But Company Pushes Forward with Groundbreaking Psychedelic Therapies - parameter.io

Dec 09, 2025

Dec 09, 2025

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - Asianet Newsable

Dec 09, 2025

Dec 09, 2025

Psyence BioMed (Nasdaq: PBM) advances Phase IIb trial, ibogaine supply leadership - Stock Titan

Dec 09, 2025

Dec 05, 2025

Bull Run: Why Psyence Biomedical Ltd stock appeals to dividend seekersTrade Performance Summary & Long-Term Growth Portfolio Plans - moha.gov.vn

Dec 05, 2025

Dec 05, 2025

How Psyence Biomedical Ltd. Equity Warrant stock benefits from global expansionJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Will Psyence Biomedical Ltd. Equity Warrant stock remain a Wall Street favoriteWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Will Psyence Biomedical Ltd. Equity Warrant stock sustain high P E ratiosAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser

Dec 04, 2025

Dec 04, 2025

Is Psyence Biomedical Ltd. stock attractive for growth ETFsPortfolio Risk Report & Reliable Entry Point Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Price to earnings ratio of Psyence Biomedical Ltd. Warrant 20242028 on Psyence Biomedical – NASDAQ:PBMWW - TradingView

Dec 03, 2025

Dec 03, 2025

Psyence Biomedical (PBM) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 03, 2025

Psyence Biomedical (NASDAQ:PBM) Trading Down 2.5% – Should You Sell? - Defense World

Dec 03, 2025

Nov 28, 2025

Psyence Biomedical Ltd. (PBM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 28, 2025

Nov 28, 2025

Psyence Biomedical : The Future of Human Longevity Will Be Transformational – And Nature May Hold the Key - marketscreener.com

Nov 28, 2025

Nov 27, 2025

How geopolitical tensions affect Psyence Biomedical Ltd. stockWeekly Trade Report & Safe Capital Growth Tips - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Psyence BioMed leads longevity research on psilocybin - Longevity.Technology

Nov 27, 2025

Nov 27, 2025

How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Spike Watch & Reliable Breakout Forecasts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Its Stock Has Paid Off Big Time For Psyence Biomedical Ltd - Setenews

Nov 26, 2025

Nov 26, 2025

Breakout Move: Why Psyence Biomedical Ltd. Equity Warrant stock is popular among millennialsEntry Point & Safe Capital Growth Stock Tips - moha.gov.vn

Nov 26, 2025

Nov 25, 2025

Psyence Biomedical launches psilocybin longevity research program By Investing.com - Investing.com Nigeria

Nov 25, 2025

Nov 25, 2025

Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program - Asianet Newsable

Nov 25, 2025

Nov 25, 2025

Psyence Biomedical launches psilocybin longevity research program - Investing.com

Nov 25, 2025

Nov 23, 2025

Psyence BioMed Expands Ibogaine Operations in Africa with Strategic Investment - MSN

Nov 23, 2025

Nov 23, 2025

Psyence Biomedical Ltd. (PBM) -13.37% in Normal Trading: Decline Amid Recent Breakthrough Announcement - Stocks Telegraph

Nov 23, 2025

Nov 23, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Nov 23, 2025

Nov 21, 2025

[6-K] PSYENCE BIOMEDICAL LTD. Current Report (Foreign Issuer) | PBM SEC FilingForm 6-K - Stock Titan

Nov 21, 2025

Nov 21, 2025

Psyence Biomedical Reports Strong Financial Growth in Latest Interim Results - MSN

Nov 21, 2025

Nov 21, 2025

Will Psyence Biomedical Ltd. stock rally after Fed decisionsPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com

Nov 21, 2025

Nov 21, 2025

Is Psyence Biomedical Ltd. stock in correction or buying zoneWeekly Trading Summary & Weekly Setup with ROI Potential - newser.com

Nov 21, 2025

Nov 21, 2025

The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews

Nov 21, 2025

Nov 21, 2025

How Psyence Biomedical Ltd. Equity Warrant stock reacts to job market dataJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com

Nov 21, 2025

Nov 20, 2025

Psyence BioMed secures sustainable iboga supply for clinical research By Investing.com - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

[424B3] PSYENCE BIOMEDICAL LTD. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan

Nov 20, 2025

Nov 20, 2025

Is PBM’s Market Boost a Fleeting Mirage? - StocksToTrade

Nov 20, 2025

Nov 20, 2025

Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025 - ts2.tech

Nov 20, 2025

Nov 20, 2025

Is It Time to Buy PBM Stock? - timothysykes.com

Nov 20, 2025

Nov 20, 2025

Psyence BioMed secures sustainable iboga supply for clinical research - Investing.com

Nov 20, 2025

Nov 20, 2025

Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets - The Manila Times

Nov 20, 2025

Nov 20, 2025

Psyence BioMed Reaches Major Breakthrough in - GlobeNewswire

Nov 20, 2025